Trials / Completed
CompletedNCT00511602
Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes
Efficacy and Safety of Inhaled Technosphere Insulin Compared to Technosphere Placebo in Patients With Type 2 Diabetes Mellitus Following Diabetes Education
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Mannkind Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective to evaluate the effect of a 12-week treatment period with prandial administration of Technosphere Insulin on glucose control in subjects with T2 DM. Secondary objective is to Evaluate the safety and tolerability of a 12-week treatment period of Technosphere Insulin and Technosphere Placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Technosphere Insulin | Technosphere Insulin Inhalation Powder |
| DRUG | Technosphere Placebo | Technosphere Inhalation Powder |
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2004-11-01
- Completion
- 2005-12-01
- First posted
- 2007-08-06
- Last updated
- 2012-04-30
Source: ClinicalTrials.gov record NCT00511602. Inclusion in this directory is not an endorsement.